The present invention relates to compositions and methods for treating eye diseases and disorders. Specifically, the invention relates to the use of an effective amount of progesterone in the manufacture of a pharmaceutical composition for treating ocular surface diseases or disorders by topical administration of the pharmaceutical composition to the forehead or temple region of a subject.